Solvency II criticised for ‘inappropriate’ stress test

European regulators have come under fire for choosing an “inappropriate” way to measure the stress caused by private equity investments on insurance companies. Research from Partners Group suggests the regulator’s favoured method of calculating private equity risks, as part of Solvency II, is not representative of the asset class as a whole.